Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation将参加湖街资本市场第八届年度最佳创意增长（BIG）会议
Download as PDFSeptember 09, 2024
以 PDF 格式下载 2024 年 9 月 9 日
SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration ("FDA")-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will attend one-on-one meetings at the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference, scheduled to take place on Thursday, September 12, 2024 in New York City.
亚利桑那州斯科茨代尔，2024年9月9日（GLOBE NEWSWIRE）——Journey Medical Corporation（“Journey Medical” 或 “公司”）（纳斯达克股票代码：DERM）是一家商业阶段制药公司，主要专注于销售和营销经美国食品药品监督管理局（“FDA”）批准的用于治疗皮肤病的处方药产品，今天宣布，总裁兼首席执行官克劳德·马拉维官员将参加湖街资本市场第八届年度最佳创意增长（BIG）会议的一对一会议，该会议定于将于 2024 年 9 月 12 日星期四在纽约市举行。
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical") is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology's most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical's common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission ("SEC"). For additional information about Journey Medical, visit .
关于旅程医疗公司
Journey Medical Corporation（纳斯达克股票代码：DERM）（“Journey Medical”）是一家商业阶段的制药公司，主要通过其高效的销售和营销模式，销售和营销经美国食品药品管理局批准的用于治疗皮肤病的处方药产品。该公司目前销售七种品牌和两种仿制产品，这些产品有助于治疗和治愈常见的皮肤病。Journey Medical团队由行业专家组成，他们在开发和商业化皮肤科一些最成功的处方品牌方面拥有丰富的经验。Journey Medical位于亚利桑那州斯科茨代尔，由丰泽生物技术公司（纳斯达克股票代码：FBIO）创立。Journey Medical的普通股根据经修订的1934年证券交易法注册，并定期向美国证券交易委员会（“SEC”）提交报告。有关 Journey Medical 的更多信息，请访问。
Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
公司联系人：
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
媒体关系联系人：
托尼·普洛霍罗斯
6 度
(908) 591-2839
tplohoros@6degreespr.com
Source: Journey Medical Corporation
资料来源：旅程医疗公司
Released September 9, 2024
2024 年 9 月 9 日发布
